Innovent Biologics, Inc. (FRA:6IB)
Germany · Delayed Price · Currency is EUR 8.65
-0.05 (-0.57%)
At close: Jan 30, 2026
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of €15.16 billion as of January 30, 2026. Its market cap has increased by 124.00% in one year.
Market Cap
15.16B
Enterprise Value
14.43B
Revenue
1.36B
Ranking
n/a
PE Ratio
112.65
Stock Price
€8.65
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 2.09B to 15.16B, an increase of 625.92%. That is a compound annual growth rate of 31.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 15.16B | 4.76% |
| Dec 31, 2025 | 14.47B | 94.12% |
| Dec 31, 2024 | 7.46B | -6.93% |
| Dec 29, 2023 | 8.01B | 29.87% |
| Dec 30, 2022 | 6.17B | -22.46% |
| Dec 31, 2021 | 7.96B | -34.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.48B |
| Mainova AG | 2.45B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.80B |
| tonies SE | 1.14B |
| Sedlmayr Grund und Immobilien AG | 932.55M |
| Berliner Effektengesellschaft AG | 879.96M |
| Northern Data AG | 842.90M |